Ultralife Corporation
ULBI
$5.46
-$0.07-1.27%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 1.87M | 291.00K | 258.00K | 2.97M | 2.89M |
| Total Depreciation and Amortization | 1.36M | 1.18M | 994.00K | 1.02M | 968.00K |
| Total Amortization of Deferred Charges | 65.00K | 47.00K | 12.00K | 16.00K | 16.00K |
| Total Other Non-Cash Items | 585.00K | 249.00K | 92.00K | 927.00K | 824.00K |
| Change in Net Operating Assets | -502.00K | 1.28M | 3.39M | 4.00M | -4.78M |
| Cash from Operations | 3.37M | 3.05M | 4.75M | 8.93M | -81.00K |
| Capital Expenditure | -895.00K | -606.00K | -594.00K | -360.00K | -372.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -48.02M | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -895.00K | -48.63M | -594.00K | -360.00K | -372.00K |
| Total Debt Issued | -- | 55.00M | -- | -- | -- |
| Total Debt Repaid | -687.00K | -8.04M | -4.03M | -13.18M | -500.00K |
| Issuance of Common Stock | -- | 39.00K | 24.00K | 1.25M | 685.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -1.32M | -68.00K | -- | -- |
| Cash from Financing | -687.00K | 45.68M | -4.08M | -11.93M | 185.00K |
| Foreign Exchange rate Adjustments | 79.00K | -18.00K | 9.00K | -46.00K | 89.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.87M | 80.00K | 84.00K | -3.41M | -179.00K |